Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
BackgroundAcute myeloid leukemia (AML) is a clonal malignant disease with poor prognosis and a low overall survival rate. Although many studies on the treatment and detection of AML have been conducted, the molecular mechanism of AML development and progression has not been fully elucidated. The pre...
Main Authors: | Ying Qu, Shuying Zhang, Yanzhang Qu, Heng Guo, Suling Wang, Xuemei Wang, Tianjiao Huang, Hong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2020.566024/full |
Similar Items
-
Prognostic significance of CXCR4 expression in acute myeloid leukemia
by: Wen Du, et al.
Published: (2019-11-01) -
Dysregulation of CCAAT/enhancer binding protein-alpha (CEBPA) expression in the bone marrow of acute myeloid leukemia patients
by: Naglaa M. Hassan, et al.
Published: (2021-04-01) -
Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
by: Melat T. Gebru, et al.
Published: (2020-11-01) -
FLT3 inhibitors: clinical potential in acute myeloid leukemia
by: Hospital MA, et al.
Published: (2017-02-01) -
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations
by: Naval Daver, et al.
Published: (2020-08-01)